Date Title Description PDF
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download

Pages

Date Title Description PDF
13 May 2020 On business and financial situation ROVI releases the presentation related to the first quarter 2020 financial results Download
13 May 2020 Interim Management Report The company releases the press release related to the 2020 first quarter financial results Download
02 Apr 2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the first quarter of 2020 Download
02 Apr 2020 On business and financial situation ROVI informs on the impact of Covid‑19 on the company’s activities Download
26 Feb 2020 Information on P&L ROVI releases the full year 2019 results presentation Download

Pages

Date Title Description PDF
07 Nov 2019 Information on P&L ROVI releases the first nine months 2019 results presentation Download
03 Oct 2019 Liquidity contracts and specialists Liquidity contract: transactions conducted in the third quarter of 2019 Download
05 Sep 2019 Others on business performance and financial information The Company informs about the construction of a second heparin plant in Granada Download
30 Jul 2019 Information on P&L ROVI releases the first half 2019 results presentation Download
30 Jul 2019 Information on P&L ROVI releases the press release related to the first half 2019 financial results Download

Pages